A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Researchers are looking for a better way to treat children and young adults who have
heart failure with left ventricular systolic dysfunction (LVSD). Heart failure with left
ventricular systolic dysfunction (LVSD) is a condition where the left side of the heart
is we...
Age: Birth - 18 years
Gender: All
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Researchers are looking for a better way to treat children who have heart failure with
left ventricular systolic dysfunction (LVSD). Heart failure is a serious condition where
the heart is unable to pump enough blood to meet the body's needs. This can lead to
symptom...
Age: 6 months - 17 years
Gender: All
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
This prospective, multicenter, cluster-randomized controlled study aims to evaluate the
accuracy of an investigational artificial intelligence (AI) Software as a Medical Device
(SaMD) designed to compute ejection fraction (EF) severity categories based on the
America...
Age: 18 years - 66+
Gender: All
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
The goal of this study is to evaluate the safety and efficacy of the BrioVAD System by
demonstrating non-inferiority to the HeartMate 3 Left Ventricular Assist System when used
for the treatment of advanced, refractory, left ventricular heart failure.
Age: 18 - 100 years
Gender: All